Skip to content
Home/Companies/Pharma/AMCo

AMCo

Pharma·UK·Exited 2015·Held 3yr
Entry
2012
Hold
3yr
Exit
2015

Who owns AMCo?

AMCo was owned by Cinven through Cinven Fifth Fund (2012 vintage) from 2012 to 2015, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Cinven
Investor
Cinven
Cinven Fifth Fund · 2012 · Buyout

Key facts

HQUK
SectorPharma
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2015

More from Cinven Fifth Fund

Other portfolio companies in the same fund.

Labco
Active
MedTechFrance· 2015
Premium Credit
Exited 2022
FintechUK· 2015
to
SYNLAB
Synlab
Active
MedTechUK· 2015
Tractel
Tractel
Exited 2022
IndustrialsFrance· 2015
to
Medpace
Exited 2017
HealthcareUS· 2014
to
Northgate Public Services
Exited 2018
TMTUK· 2014
to

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track AMCo

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy AMCo?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on AMCo.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue